Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 1.6
-5.88 %
$ 315 M
Market Cap
-2.39
P/E
ESPR - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities ESPR - Esperion Therapeutics, Inc.
42.5 M
LAST VALUE
68.58%
2 YEAR CAGR
-21.26%
5 YEAR CAGR
14.94%
10 YEAR CAGR